Как работает иммунитет

Faurschou M., Borregaard N.Neutrophil granules and secretory vesicles in inflammation. // Microbes Infect. 2003. Vol. 5, № 14. P. 1317–1327.

ArataniY. Myeloperoxidase: itsroleforhostdefense, inflammation, andneutrophilfunction. // ArchBiochemBiophys. 2018. Vol. 15, № 640. P. 47–52.

Farnaud S., Evans R.W. Lactoferrin – a multifunctional protein with antimicrobial properties. // Mol Immunol. 2003. Vol. 40, № 7. P. 395–405.

Кокряков В.Н. Очерки о врожденном иммунитете. – СПб.: Наука, 2006 – 260 с.

Cotter P.D., R. Ross R.P., Hill C. Bacteriocins – a viable alternative to antibiotics? // Nat Rev Microbiol. 2013. Vol. 11. P. 95–105.

Zeya H.I., Spitznagel J.K. Antimicrobial specificity of leukocyte lysosomal cationic proteins // Science. 1966. Vol. 154, № 3752. P. 1049–1051; Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., Lehrer R.I. Defensins. Natural peptide antibiotics of human neutrophils // J. Clin. Invest. 1985. V. 76, № 4. P. 1427–1435.

Phoenix D.A., Dennison S.R., Harris F. Antimicrobial peptides. Wiley-VCH Verlag GmbH & Co. KGaA, 2013, – 231 pp.

ZhangL. Antimicrobialpeptides. / ZhangL., GalloR.L // CurrentBiology. 2016. – V.26, – P. R1–R21.

Kang H.K., Kim C., Seo C.H., Park Y. The therapeutic applications of antimicrobial peptides (AMPs): a patent review. // J Microbiol. 2017. Vol. 55, № 1. P. 1–12).

(Кокряков В.Н. Очерки о врожденном иммунитете. – СПб.: Наука, 2006 – 260 с..

Hoskin D.W., Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. // Biochim Biophys Acta. 2008. Vol. 1778, № 2. P. 357–375; Roudi R., Syn N.L., Roudbary M. Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview. // Front Immunol. 2017. Vol. 8. Article 1320.

Abul Abbas, Andrew H. Lichtman, Shiv Pillai. Cellular and molecular immunology. 9thed. Elsiever – 608pp.

Dinarello C.A. Historical review of cytokines. // Eur J Immunol. 2007. Vol. 37. Suppl 1. P. S34–S45.

Akdis M., Burgler S., Crameri R., Eiwegger T., Fujita H., Gomez E., Klunker S., Meyer N., O’Mahony L., Palomares O., Rhyner C., Ouaked N., Schaffartzik A., Van De Veen W., Zeller S., Zimmermann M., Akdis C.A. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. // J Allergy Clin Immunol. 2011. Vol. 127, № 3. P. 701–721.

Parkin J., Cohen B. An overview of the immune system. // Lancet. 2001. Vol. 357, № 9270. P. 1777–1789.

Pestka S. The interferons: 50 years after their discovery, there is much more to learn. // Journal Biol Chem. 2007. Vol. 282, № 28. P. 20047-20051.

Baldo B.A. Side effects of cytokines approved for therapy. // Drug Saf. 2014. Vol. 37. P. 921–943.

Mélik-Parsadaniantz S., Rostène W. Chemokines and neuromodulation. // Journal Neuroimmunol. 2008. Vol. 198, № 1–2. P. 62–68.

Dinarello C.A. Historical review of cytokines. // Eur J Immunol. 2007. Vol. 37. Suppl 1. P. S34–S45.

Черешнев В.А., Шмагель К.В. Иммунология. Учебник для вузов. – М.: Магистр-Пресс, 2013. – 448 с.

Chen K., Cerutti A. The function and regulation of immunoglobulin D. // Curr Opin Immunol. 2011. Vol. 23, № 3. P. 345–352.

Шенфельд И., Мерони П.Л., Чурилов Л.П… Руководство по аутоиммунным заболеваниям для врачей общей практики; пер. с англ. СПб.: Элби-СПб. 2017, – 416 с.; Rowley M.J., Whittingham S.F. The role of pathogenic autoantibodies in autoimmunity. // Antibodies. 2015. Vol. 4. P. 314–353.

Chard T. Pregnancy tests: a review. // Hum Reprod. 1992. Vol. 7, № 5. P. 701–710.

Weiner L.M., Dhodapkar M.V., Ferrone S. Monoclonal antibodies for cancer immunotherapy. // Lancet. 2009. Vol. 373, № 9668. P. 1033–1040; Weiner L.M., Murray J.C., Shuptrine C.W. Antibody-based immunotherapy of cancer: new insights, new targets. // Cell. 2012. Vol. 148, № 6. P. 1081–1084; Karyampudi L., Knutson K.L. Antibodies in cancer immunotherapy. // Cancer Biomark. 2010. Vol. 6, № 5–6. P. 291–305).

Catty D. Antibodies: a practical approach / D. Catty. – Oxford University Press, USA, – 1988. – 259 pp.

Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: pathophysiological mechanisms // J. Immunol. 2013. V. 190, № 8. P. 3831–3838.

Merle N.S., Noe R., Halbwachs-Mecarelli L., Fremeaux-Bacchi V., L.T. Roumenina L.T. Complement system part I – molecular mechanisms of activation and regulation. // Front Immunol. 2015.V.6. Article 262.

Merle N.S., Noe R., Halbwachs-Mecarelli L., Fremeaux-Bacchi V., L.T. Roumenina L.T. Complement system part II: Role in immunity // Front Immunol. 2015. V.6. Article 257.

Abul Abbas, Andrew H. Lichtman, Shiv Pillai. Cellular and molecular immunology. 9thed. Elsiever – 608pp.

Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. // Cold Spring Harb. Symp. Quant. Biol. 1989. Vol. 54, P. 1–13.

Park B.S., Lee J.-O. Recognition of lipopolysaccharide pattern by TLR4 complexes. // Exp Mol Med. 2013. Vol. 45, № 12. e66.